However, there was a significant reduction in the MDA levels and a significant increase in GSH but not G6PD levels following administration of SPL in experimental PCOS animals compared with untreated PCOS animals (Fig. 3, supplementary table 4, 5 and 6). This evidence concerns the gene G6PD and polycystic ovary syndrome.